about
Cerebral venous sinus thrombosis associated with cerebral hemorrhage: is anticoagulant treatment safe?[Pain in multiple sclerosis: prevalence, mechanisms, types and treatment].TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or NatalizumabSpatial and temporal gene expression differences in core and periinfarct areas in experimental stroke: a microarray analysis.Varicella-zoster virus vasculopathy. A review description of a new case with multifocal brain hemorrhage.Treatment with natalizumab in relapsing-remitting multiple sclerosis patients induces changes in inflammatory mechanismClinically isolated syndromes suggestive of multiple sclerosis: an optical coherence tomography study.New goals in ischemic stroke therapy: the experimental approach--harmonizing science with practice.General care in stroke: relevance of glycemia and blood pressure levels.Poststroke depression: importance of its detection and treatment.Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic strokeStroke related to systemic illness and complicated surgery.Cerebral protection, brain repair, plasticity and cell therapy in ischemic stroke.Trophic factors and cell therapy to stimulate brain repair after ischaemic stroke.Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials.Circulating Monocytes Exhibit an Endotoxin Tolerance Status after Acute Ischemic Stroke: Mitochondrial DNA as a Putative Explanation for Poststroke Infections.Cyclophosphamide-induced reversible posterior leukoencephalopathy syndrome.[Retinopathy and renal failure in a patient with multiple sclerosis under treatment with beta-interferon].Stroke: The worldwide burden of stroke--a blurred photograph.The effect of telestroke systems among neighboring hospitals: more and better? The Madrid Telestroke Project.In-hospital stroke treated with intravenous tissue plasminogen activator.Evaluation of maximal respiratory pressures in myasthenia gravis. Prognostic value.CDP-choline at high doses is as effective as i.v. thrombolysis in experimental animal stroke.Acute ischemic stroke patients with diabetes should not be excluded from intravenous thrombolysis.CDP-choline treatment induces brain plasticity markers expression in experimental animal stroke.Changes in carotid plaque echogenicity with time since the stroke onset: an early marker of plaque remodeling?Questionable reversal of anticoagulation in the therapeutic management of cerebral haemorrhage associated with vitamin K antagonists.Benefits of intravenous thrombolysis in acute ischemic stroke related to extra cranial internal carotid dissection. Dream or reality?The Iberoamerican Cerebrovascular Diseases Society: 15 years moving forward.Female gender is a factor of worse outcome in acute stroke even after thrombolytic treatment.Transient floating thrombus of the internal carotid artery associated with the JAK2V617F mutation.Intravenous thrombolysis in stroke patients under 55 years of age: is there a different effect according to etiology and severity?Treatment with statins and ischemic stroke severity: Does the dose matter?Síndrome de Bruns causado por neurocisticercosis intraventricularNoninvasive Imaging of Carotid Giant Pseudoaneurysm[Vestibular syndrome: when the correct differential diagnosis can be vital]High Doses of Statins and Stroke OutcomeTreatment with angiotensin receptor blockers before stroke could exert a favourable effect in acute cerebral infarctionMigraña y alteraciones del septo auricular en pacientes menores de 55 años con infarto cerebral criptogenéticoConsistency of the Benefits of Stroke Units over Years of Operation: An 8-Year Effectiveness Analysis
P50
Q33945274-A23DDD13-1FE8-4217-973E-FC8870A23247Q34095595-6B035307-66CB-4AF4-A39C-D59CBEA5377EQ34418098-FA197E3B-2F0D-4FDF-9AEF-7947CB338305Q34533044-3EFE6FBE-5EB2-46F2-BDC7-C74E7E5130E5Q35086098-F0BEBE86-D12E-4D4E-9094-726B7FCD7F35Q35163712-A080F3C2-1553-4E73-B6EE-D1B71D0EFEE6Q35842564-9855918F-6774-4827-82CD-D02FB9EDBFD9Q36331049-3CBD96AE-3133-4A89-8AD9-FA95B7877C03Q36986422-C2106CAF-8545-4442-935E-D853C29E7254Q36986445-8B4DFC89-5648-4814-BC44-A1AF7B867BDCQ36997873-74D434D4-7F2C-4C6D-A74E-B8A2032DD389Q37274436-A4F46DCB-EBC3-4C3C-8B5C-6E462B461CABQ37431318-1072B8B1-EE91-4B12-A1C2-1FEA36CF4181Q37997539-CC552FBB-2D4B-4305-AB16-8959CB6516EEQ38071519-9D7A5A7B-47D8-4F65-8A51-A8EEA4FA0C01Q39003422-F800D849-DDD4-49C4-8B5A-039FAFFE3821Q42580693-82C17510-83EB-4E08-A1AF-BAE2D736EDF1Q43170894-43F05561-2B89-4EB8-BBE1-0368DB0904E7Q44037407-DCE44A9A-AA57-4FF8-999A-A8123B1DE92CQ44145182-0A10F083-1FAE-4D95-8F04-0EC4BAC8B4CFQ44358374-B96D2D10-B037-4391-ADC4-2CAB00E2D2F1Q47913301-2E23C629-2AC6-4464-BE66-C001528FF06FQ48461119-ACCD9C67-FB9A-4C9F-8D76-88EBBC2F4A07Q48671195-E564DD2D-50C7-4B90-A3B2-C980411E0A5FQ48723286-F1CB2A0C-75C2-4C70-B5E8-1EDC53F04452Q48768030-45AF3C39-F983-438F-9D5E-0AB91EB9BBB3Q50773882-7A8189A5-9CD5-4C76-ABDB-C3E8D2E7380EQ50998993-EB806945-D4E8-4265-8419-EEEFCC727422Q51214476-BAA25DBD-55CD-47A7-8160-FD0AFAE8CF06Q51439726-D5F50C03-3356-43FC-B7C7-1F42ED1158B6Q54548057-F8FF6860-AD65-4ABE-BC99-F7BE9356D6E1Q59846676-3CCF96C8-0F56-4B50-B564-2CDA919476CFQ59846930-078A79DA-6583-441A-B76F-3C6C85405696Q59847189-12CB0DE0-D5D7-45EB-B155-9B761647F536Q59847328-909F9A29-621A-4CEB-9E64-0ECCC36319C3Q59847344-7FF06AB1-8903-4240-B026-59D05E3F209BQ59847359-18123D2B-D60C-4207-92E7-F987DF793C86Q59847393-EF0E56EA-7887-4DF4-881E-EDA105D66EDCQ59847688-CC0C952F-AF60-422B-81AE-918C6C0D72FCQ59847762-D9955D47-39E3-4EAE-831A-8A070B55E807
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Exuperio Díez Tejedor
@ast
Exuperio Díez Tejedor
@en
Exuperio Díez Tejedor
@es
Exuperio Díez Tejedor
@nl
type
label
Exuperio Díez Tejedor
@ast
Exuperio Díez Tejedor
@en
Exuperio Díez Tejedor
@es
Exuperio Díez Tejedor
@nl
prefLabel
Exuperio Díez Tejedor
@ast
Exuperio Díez Tejedor
@en
Exuperio Díez Tejedor
@es
Exuperio Díez Tejedor
@nl
P106
P31
P496
0000-0003-2295-1707